Merit-based Incentive Payment System

Merit-based Incentive Payment System
U.S. Government · Public domain · source
Name	Merit-based Incentive Payment System
Established	2017
Administered by	Centers for Medicare & Medicaid Services
Country	United States
Type	Health care payment program
Purpose	Quality reporting and payment adjustment for eligible clinicians

Merit-based Incentive Payment System

The Merit-based Incentive Payment System is a United States federal clinician payment program that adjusts Medicare Part B reimbursement based on performance. It aligns with value-based initiatives from the Affordable Care Act, Centers for Medicare & Medicaid Services, Department of Health and Human Services, and interacts with alternative payment models associated with Medicare and Medicaid. The program influences reporting and payment flows across physician groups, hospitals, and health systems including interactions with Patient Protection and Affordable Care Act provisions and federal rulemaking.

Overview

The program was created under the Medicare Access and CHIP Reauthorization Act of 2015 and operationalized by the Centers for Medicare & Medicaid Services through annual final rules and notice-and-comment rulemaking, alongside oversight from the Office of Inspector General and policy guidance from the Congressional Budget Office. Stakeholders such as the American Medical Association, American Hospital Association, American Nurses Association, Federation of American Hospitals, and trade groups like the Medical Group Management Association and American Academy of Family Physicians engaged in rule development. Implementation interacts with initiatives from Agency for Healthcare Research and Quality, procurement processes at the General Services Administration, and technical specification efforts led by Health Level Seven International. The program’s metrics align with reporting standards set by National Committee for Quality Assurance, Joint Commission, and federal quality partners including the National Quality Forum.

Eligibility and Participation

Eligible clinicians and organizations include Medicare Part B clinicians aligned with billing and claims thresholds established by the Centers for Medicare & Medicaid Services and administrative guidance from the Internal Revenue Service and Department of Health and Human Services Office of Inspector General. Participating entities include solo practitioners, physician groups, ambulatory surgery centers, and specialty practices such as American College of Surgeons members, American College of Cardiology clinics, and American Psychiatric Association providers who meet participation criteria. Methods for participation involve registration with Centers for Medicare & Medicaid Services systems, submission to data registries like the National Cardiovascular Data Registry, or collection through certified electronic health record technology overseen by Office of the National Coordinator for Health Information Technology. Program rules reference performance thresholds, virtual groups, and exemptions analogous to provisions considered by the Senate Committee on Finance and House Committee on Ways and Means.

Performance Categories and Scoring

Performance assessment is divided into categories including Quality, Promoting Interoperability, Improvement Activities, and Cost, with technical specs informed by the National Quality Forum and measurement frameworks used by the Agency for Healthcare Research and Quality. Quality measures include process and outcome metrics similar to those in registries like the Society of Thoracic Surgeons database and reporting frameworks from the American College of Obstetricians and Gynecologists. Promoting Interoperability builds on standards from Health Level Seven International and certification criteria from the Office of the National Coordinator for Health Information Technology. Improvement Activities align with guidance from specialty societies such as the American Academy of Pediatrics, American College of Physicians, and American Academy of Family Physicians. Cost metrics derive from Medicare claims analytics developed by Centers for Medicare & Medicaid Services actuaries and economic modeling used by the Congressional Budget Office.

Payment Adjustments and Calculation Methodology

Payment adjustments are budget-neutral and applied to Medicare Part B fee-for-service payments through modulation influenced by baseline conversion factors set by law and rulemaking from Centers for Medicare & Medicaid Services. Calculation methods use claims-based scoring, benchmarking against national performance and historical performance windows, with actuarial inputs akin to those used by the Social Security Administration in benefit calculations and the Centers for Medicare & Medicaid Services Office of the Actuary. Adjustments may be positive or negative within legislatively constrained maximums, and small practices can elect subgrouping through virtual groups similar to arrangements negotiated by the American Medical Association or coordinated via regional entities like Health Resources and Services Administration grant recipients. Payment impact modeling has been examined by the Government Accountability Office and Congressional Budget Office.

Policy History and Legislative Background

Legislative roots trace to the Medicare Access and CHIP Reauthorization Act of 2015 signed during the 114th United States Congress and subsequent regulatory refinement during the 115th United States Congress and 116th United States Congress. Administrative implementation involved rulemakings published in the Federal Register and interactions with budgetary guidance from the Office of Management and Budget. Advocacy and litigation have involved national organizations such as the American Medical Association and American Hospital Association, and oversight reviews by the Government Accountability Office and Office of Inspector General have shaped policy adjustments. Subsequent legislation and appropriations debates in the United States Senate and United States House of Representatives influenced program scope, especially during deliberations on Medicare payment reform and value-based purchasing experiments overseen by Congressional Budget Office analyses.

Impact, Criticisms, and Evaluations

Evaluations by agencies and academic centers such as the RAND Corporation, Commonwealth Fund, Urban Institute, and research published in journals associated with New England Journal of Medicine and Health Affairs have examined clinical impact, administrative burden, and cost-effectiveness. Criticisms from specialty societies including the American College of Emergency Physicians, American College of Surgeons, and American Psychiatric Association have focused on measure validity, clinician burden, and unintended consequences for access to care, echoing concerns raised by the National Rural Health Association and patient advocacy groups like AARP. Empirical assessments by the Government Accountability Office and peer-reviewed analyses from institutions such as Harvard Medical School, Johns Hopkins University, and Stanford University have reported mixed effects on quality improvement and spending, prompting ongoing rule revisions by the Centers for Medicare & Medicaid Services and legislative scrutiny by committees in the United States Congress.

Category:United States federal health programs